The three themes of the Pharmaceutical Technology annual conference, 24-26 July 2007 at the Park Hyatt at the Bellevue, Philadelphia, are lean design, quality initiatives, and cutting-edge technology
Pharmaceutical Technology's annual conference was produced in conjunction with an expert advisory board, four members of which sit on Pharmaceutical Technology's editorial advisory board.
According to Richard Hwang, senior director of pharmaceuticals at Pfizer Global R+D and a member of both the Pharmaceutical Technology editorial and event advisory boards: "The three themes of the Pharm Tech Conference this year - lean design, quality initiatives, and cutting-edge technology - really touch the critical fronts of the pharmaceutical industry".
Over 30 presentations and case studies from top industry players including AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, FDA, Cordis, Merck, Novartis, Schering-Plough, Wyeth are a part of this year's conference.
Highlights include a keynote presentation on the US FDA's Pharmaceutical Quality Assessment in the 21st Century - A Modern Risk-Based Approach, presented by Moheb Nasr, director, Office of New Drug Quality Assessment, CDER, FDA.
This presentation will take place at 1:45pm on day one of the conference.
In addition there will be an industry keynote address.
On day two of the conference at 8:30am, Nirdosh Jagota, assistant vice president of Wyeth Research will be presenting on Quality by Design (QbD)-Industrial Perspective.
Another new highlight for the 2007 conference is a panel discussion on technology transfer - best practices and industry experiences for bridging R+D to manufacturing.
Panelists are from Pfizer Global R+D, Bristol-Myers Squibb, Idenix Pharmaceuticals, Merck Research Labs, and Pfizer.
A number of timely and exciting topics related to optimising process excellence are covered in the areas of lean design and development, quality initiatives, and cutting edge technology.
Lean design and development topics covered include applications on all levels from R+D through manufacturing including Six Sigma, validation, formulation development, clinical supply manufacturing, pharmaceutical processes, and manufacturing product lines.
Pharmaceutical quality initiatives in the 21st century topics covered include quality by design (QbD), ICH Q8, ICH Q9, quality systems, process analytical technology (PAT), design of experiments (DOE), and risk assessment.
Cutting edge technology topics covered include PAT, ultra performance liquid chromatography (UPLC), ScanRDI, laser induced breakdown technology (Libs), data automation, mathematical modelling, and process transfer.
